Pre-clinical evaluation of the MDM2-p53 antagonist RG7388 alone and in combination with chemotherapy in neuroblastomaLindi Chen, Deborah A. Tweddle|Oncotarget|2015Cited by 89
Structurally diverse MDM2–p53 antagonists act as modulators of MDR-1 function in neuroblastomaL Chen, Deborah A. Tweddle|British Journal of Cancer|2014Cited by 42